TG(54:4)
|
Basic information |
| Metabolite name | TG(54:4) |
 | N/A |
 |
C00422 |
 |
N/A |
| Synonyms | TAG(54:4) |
| No. of studies | 5 |
|
Basic information |
| Metabolite name | TG(54:4) |
| N/A |
|
C00422 |
|
N/A |
| Synonyms | TAG(54:4) |
| No. of studies | 5 |
|
Relationship between TG(54:4) and depression (count: 5) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M125 | Type1 | depressed group vs. control group | Plasma | Human | Up |
| Study M613 | Type1 | CSDS susceptible group vs. control group | Medial prefrontal cortex | C57BL/6 J mouse | Down |
| Study M734 | Type2 | CRS + acupuncture group vs. CRS group | Liver | C57BL/6 mouse | Up |
| Study M775 | Type1 | prenatal stress group vs. control group | Brain | Swiss Webster mouse | Up |
| Study M789 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Down |
| Study M789 | Type2 | CUMS + liquiritin group vs. CUMS group | Plasma | Sprague-Dawley rat | Up |
| Study M789 | Type2 | CUMS + fluoxetine group vs. CUMS group | Plasma | Sprague-Dawley rat | Up |